Pnc Financial Services Group, Inc. Iovance Biotherapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 609 shares of IOVA stock, worth $3,221. This represents 0.0% of its overall portfolio holdings.
Number of Shares
609
Previous 931
34.59%
Holding current value
$3,221
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding IOVA
# of Institutions
324Shares Held
244MCall Options Held
3.91MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.5MShares$146 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$141 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$127 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$112 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$69.8 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $835M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...